Prabhash Nath Tripathi

1.7k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Prabhash Nath Tripathi is a scholar working on Pharmacology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Prabhash Nath Tripathi has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 13 papers in Computational Theory and Mathematics and 10 papers in Organic Chemistry. Recurrent topics in Prabhash Nath Tripathi's work include Cholinesterase and Neurodegenerative Diseases (16 papers), Computational Drug Discovery Methods (13 papers) and Medicinal Plants and Neuroprotection (5 papers). Prabhash Nath Tripathi is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (16 papers), Computational Drug Discovery Methods (13 papers) and Medicinal Plants and Neuroprotection (5 papers). Prabhash Nath Tripathi collaborates with scholars based in India, United States and United Arab Emirates. Prabhash Nath Tripathi's co-authors include Sushant K. Shrivastava, Pavan Srivastava, Piyoosh Sharma, Ankit Seth, Avanish Tripathi, Surya Pratap Singh, Sachchida Nand, Manish Tripathi, Anupam G. Banerjee and Rohit Srivastava and has published in prestigious journals such as SHILAP Revista de lepidopterología, Progress in Neurobiology and Organic Letters.

In The Last Decade

Prabhash Nath Tripathi

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants

2024 80 citations Prabhash Nath Tripathi, Sachchida Nand et al. PubMed profile →

Peers

Countries citing papers authored by Prabhash Nath Tripathi

Since Specialization

Citations

This map shows the geographic impact of Prabhash Nath Tripathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabhash Nath Tripathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabhash Nath Tripathi more than expected).

Fields of papers citing papers by Prabhash Nath Tripathi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabhash Nath Tripathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabhash Nath Tripathi. The network helps show where Prabhash Nath Tripathi may publish in the future.

Co-authorship network of co-authors of Prabhash Nath Tripathi

This figure shows the co-authorship network connecting the top 25 collaborators of Prabhash Nath Tripathi. A scholar is included among the top collaborators of Prabhash Nath Tripathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabhash Nath Tripathi. Prabhash Nath Tripathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor “Avanafil” via Modulating cAMP & cGMP Pathway Against Alzheimer’s Disease 2025 ·Neurochemical Research ·(unknown), (unknown), Prabhash Nath Tripathi, (unknown)	0
2	Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants breakdown → 2024 ·PubMed ·Prabhash Nath Tripathi, (unknown), Sachchida Nand, (unknown), Shweta Dumoga, (unknown), (unknown), Santosh Kumar Singh, Abdel‐Nasser El‐Shorbagi, (unknown)	80
3	Emerging Trends: Neurofilament Biomarkers in Precision Neurology 2024 ·Neurochemical Research ·Priti Sharma, (unknown), Prabhash Nath Tripathi	15
4	Multifaceted Neuroprotective Role of Punicalagin: A Review 2023 ·Neurochemical Research ·(unknown), (unknown), Anurag Chaudhary, Prabhash Nath Tripathi, (unknown), (unknown)	21
5	Beta-Lactamases Inhibitors: A Perspective on the Existing and the Potential Admixtures to Synergize Beta-lactams Versus Resistant Superbugs 2022 ·Biomedical & Pharmacology Journal ·Abdel‐Nasser El‐Shorbagi, Sachin Chaudhary, Anurag Chaudhary, Garima Agarwal, Prabhash Nath Tripathi, (unknown)	0
6	Stature Estimation from Dimension of Hands and Hand Prints in Dehradun Population 2022 ·Zenodo (CERN European Organization for Nuclear Research) ·(unknown), (unknown), Ruchi Singh, (unknown), Prabhash Nath Tripathi, Samarendra Das, (unknown)	0
7	Marine Antineoplastic Templates: Clinical trials (I-III) and Motifs Carried via Antibodies to Target Specific Cancerous Tissues 2022 ·Biomedical & Pharmacology Journal ·Abdel‐Nasser El‐Shorbagi, Sachin Chaudhary, Anurag Chaudhary, Garima Agarwal, Prabhash Nath Tripathi, (unknown), (unknown), (unknown), (unknown), (unknown), Mahmoud H. Mohamed	3
8	Novel 5,6-diphenyl-1,2,4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity 2022 ·Bioorganic Chemistry ·(unknown), Prabhash Nath Tripathi, Manish Tripathi, Avanish Tripathi, Himanshu Verma, Digambar Kumar Waiker, Royana Singh, Sushant K. Shrivastava	22
9	Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer’s disease 2020 ·Journal of Computer-Aided Molecular Design ·Manish Tripathi, Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Pavan Srivastava, Ankit Seth, Sushant K. Shrivastava	16
10	Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease 2019 ·European Journal of Medicinal Chemistry ·Avanish Tripathi, (unknown), Piyoosh Sharma, Ankit Seth, Prabhash Nath Tripathi, Manish Tripathi, Santosh Kumar Prajapati, Sairam Krishnamurthy, Sushant K. Shrivastava	57
11	Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease 2019 ·European Journal of Medicinal Chemistry ·Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Santosh Kumar Prajapati, Ankit Seth, Manish Tripathi, Pavan Srivastava, Vinod Tiwari, Sairam Krishnamurthy, Sushant K. Shrivastava	84
12	Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions 2019 ·Bioorganic & Medicinal Chemistry ·Prabhash Nath Tripathi, Pavan Srivastava, Piyoosh Sharma, Ankit Seth, Sushant K. Shrivastava	36
13	Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer’s disease 2019 ·Bioorganic & Medicinal Chemistry ·Pavan Srivastava, Prabhash Nath Tripathi, Piyoosh Sharma, Sushant K. Shrivastava	17
14	Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer’s Disease 2019 ·ACS Chemical Neuroscience ·Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Saumitra Sen Singh, Surya Pratap Singh, Sushant K. Shrivastava	53
15	Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer’s disease 2018 ·Bioorganic Chemistry ·Sushant K. Shrivastava, Saurabh K. Sinha, Pavan Srivastava, Prabhash Nath Tripathi, Piyoosh Sharma, Manish Tripathi, Avanish Tripathi, (unknown), Digambar Kumar Waiker, Lalit Mohan Aggarwal, Manish Dixit, (unknown), Sanjay Gambhir, Sharmila Shankar, Rohit Srivastava	48
16	Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory 2018 ·European Journal of Medicinal Chemistry ·Pavan Srivastava, Prabhash Nath Tripathi, Piyoosh Sharma, Sachchida Nand, Surya Pratap Singh, Rohit Srivastava, Sharmila Shankar, Sushant K. Shrivastava	171
17	Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory 2017 ·Bioorganic & Medicinal Chemistry ·Sushant K. Shrivastava, Pavan Srivastava, (unknown), Prabhash Nath Tripathi, Saurabh K. Sinha	31
18	Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity 2017 ·Bioorganic & Medicinal Chemistry ·Sushant K. Shrivastava, Pavan Srivastava, (unknown), Prabhash Nath Tripathi, Avanish Tripathi	58
19	Allyloxy and Propargyloxy Group Migration: Role of Remote Group Participation in the Synthesis of 5-C-Nucleosides and Other Sugar Derivatives 2012 ·Organic Letters ·(unknown), Prabhash Nath Tripathi, Sukhendu Mandal	7
20	Effect of Semicarpus anacardium on the cell cycle of DU-145 cells 1998 ·Phytomedicine ·Yamini Bhusan Tripathi, Prabhash Nath Tripathi, M. V. Ramana Reddy, Shilpee Dutt, D.S. Tewari, E. Premkumar Reddy	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact